Clover Health Investments Corp
NASDAQ:CLOV

Watchlist Manager
Clover Health Investments Corp Logo
Clover Health Investments Corp
NASDAQ:CLOV
Watchlist
Price: 4.3 USD
Market Cap: $2.3B

Clover Health Investments Corp
Investor Relations

Clover Health Investments Corp. is a U.S. health insurance company focused mainly on Medicare Advantage plans for older adults. It sells health coverage to Medicare beneficiaries, then gets paid through insurance premiums and government payments tied to the members it enrolls. Its core job is to help members get covered doctor visits, hospital care, prescription support, and other standard health benefits through its plans. What makes Clover different is that it pairs insurance with software. It uses its Clover Assistant platform to collect and organize patient data, then gives doctors and care teams tools to spot risks, manage chronic conditions, and coordinate treatment more effectively. That means Clover is not just a payer of claims; it also tries to shape how care is delivered for its members. Its main customers are Medicare-eligible consumers and, in some cases, physicians and care providers who use its tools to manage those patients. Clover makes money mainly from insurance premiums and related Medicare reimbursement for covered members, while its software and care management tools support the insurance business rather than standing alone as a separate product line.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Aug 5, 2026
AI Summary
Q2 2026

Strong quarter: Clover said second quarter Medicare Advantage membership grew 48% year over year, with $743 million of revenue, $153 million of gross profit, $41 million of adjusted EBITDA and $28 million of GAAP net income.

Guidance raised: Management increased full-year 2026 guidance across all major metrics after a strong first half, while still sounding cautious about second-half claims experience and seasonality.

2027 confidence: The company said its bigger long-term driver is cohort maturation under Clover Assistant, not just the 4.5-Star rating, and that this is strengthening its earnings outlook for 2027.

Stars outcome: All Medicare Advantage members are now in 4.5-Star plans for payment year 2027 after a court-related recalculation, though CMS has filed an appeal.

AI expansion: Clover said it plans to bring AI deeper into back-office insurance operations to speed claims, improve accuracy, and lower administrative expense over time.

Key Financials
Medicare Advantage membership growth
48%
Average Medicare Advantage membership
157,000
Total revenue
$743 million
Consolidated gross profit
$153 million
Adjusted EBITDA
$41 million
GAAP net income
$28 million
Adjusted SG&A
$112 million
Cash and investments
$443 million
Cash flow from operations
$133 million
First-half adjusted EBITDA
$81 million
First-half GAAP net income
$55 million
First-half revenue
$1.5 billion
First-half gross profit
$104 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Vivek Garipalli
Co-Founder & Executive Chairman
No Bio Available
Mr. Andrew Toy
Co-Founder, CEO & Director
No Bio Available
Ms. Karen Soares
General Counsel, Senior VP & Corporate Secretary
No Bio Available
Mr. Brady Priest J.D.
Chief Executive Officer of Home Care
No Bio Available
Ms. Jamie L. Reynoso
Chief Executive Officer of Medicare Advantage
No Bio Available
Mr. Peter J. Kuipers
Chief Financial Officer
No Bio Available
Mr. Conrad Wai
Chief Technology Officer
No Bio Available
Mr. Derrick L. Nueman
Head of Investor Relations & Corporate strategy
No Bio Available
Ms. Wendy Richey
Chief Compliance Officer
No Bio Available
Ms. Rachel Fish
Chief People Officer
No Bio Available

Contacts

Address
TENNESSEE
Franklin
3401 Mallory Lane, Suite 210, Suite 320
Contacts
+12014322133.0
www.cloverhealth.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett